# RVL Pharmaceuticals plc (RVLPQ)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RVLPQ/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ 18.48M | $ -38.39M | $ -21.87M | $ 58.15M | $ 16.33M |
| 2022 | $ 55.54M | $ -57.75M | $ -43.08M | $ 57.49M | $ 51.09M |
| 2021 | $ 48.08M | $ -77.17M | $ -67.18M | $ 47.65M | $ 76.73M |
| 2020 | $ 226.61M | $ -101.39M | $ 18.42M | $ 221.62M | $ 93.86M |
| 2019 | $ 309.82M | $ -348.76M | $ 38.12M | $ 273.30M | $ 114.71M |
| 2018 | $ 348.27M | $ -144.65M | $ 44.13M | $ 268.83M | $ 386.27M |
| 2017 | $ 175.23M | $ -20.34M | $ 23.79M | $ 320.69M | $ 419.27M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 3.56 |
| Liabilities / Eq | 4.23 |
| Current Ratio | 0.38 |

## Other views

- [Metrics](https://sponda.capital/en/RVLPQ.md)
- [Charts](https://sponda.capital/en/RVLPQ/charts.md)
- [Compare](https://sponda.capital/en/RVLPQ/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.